Alex Blyth

Alex Blyth is the current CEO of LIfT BioSciences, and has previously held the position of Head of Marketing Sciences at The MSI Consultancy, as well as Founder of Fast-Track Ventures Ltd and CELLO Business Sciences. Alex has also been Vice President at Cello Health Consulting.

Blyth has over 15 years of experience in commercial decision-making in the biopharmaceutical industry, with a focus on strategy and marketing. Alex has a proven track record in developing and implementing successful commercialisation strategies for new and existing products.

Blyth is a passionate advocate for social impact businesses, and has dedicated their career to helping these businesses realise their potential. Alex is an expert in developing winning commercial and social impact strategies, and has played a leading role in the growth and success of many companies.

Alex Blyth has a Bachelor of Science in Biological Sciences from The Open University, a Bachelor of Science in Economics from the University of Southampton, and a certification from Saïd Business School at the University of Oxford in Oxford Chicago Valuation Programme.

Some direct reports include Andrew Willis - Head of Regulatory, Panteli Theocharous - Chief Medical Officer, and Rebecca Prue - Head of Quality Control.